Medication-induced osteoporosis

被引:0
|
作者
Weng M.-Y. [1 ]
Lane N.E. [1 ]
机构
[1] Department of Medicine, University of California at Davis, Sacramento, CA 95817
关键词
Bone Mineral Density; Osteoporosis; Bone Loss; Alendronate; Zoledronic Acid;
D O I
10.1007/s11914-007-0008-y
中图分类号
学科分类号
摘要
Osteoporosis, a condition of low bone mass and microarchitectural deterioration, results in fractures with minimal trauma. Secondary osteoporosis is defined as bone loss resulting from either specific clinical disorders or medications. Some medications that can induce osteoporosis are discussed. Specifically, this article reviews the pathogenesis of glucocorticoid-induced bone loss and demonstrates the means to successfully manage the condition with a combination of calcium and vitamin D supplementation and, depending on the severity of the bone loss, bisphosphonates or parathyroid hormone. In addition, the pathphysiology of bone loss from aromatase inhibitors in women, gonadotropin-releasing hormone agonists in men, anticonvulsant medications, and proton pump inhibitors is outlined. Finally, this review offers suggestions on evaluation and management of bone health in individuals treated with these medications for prolonged times. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码:139 / 145
页数:6
相关论文
共 50 条
  • [1] Medication-induced osteoporosis: screening and treatment strategies
    Panday, Keshav
    Gona, Amitha
    Humphrey, Mary Beth
    [J]. THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2014, 6 (05) : 185 - 202
  • [2] An Overlooked Medication-Induced Celiac Flare Complicating Treatment of Osteoporosis
    Phan, Van
    Aurora Jr, John
    Gondi, Suma
    Ceglia, Lisa
    [J]. AACE CLINICAL CASE REPORTS, 2024, 10 (02): : 60 - 62
  • [3] Incidence and prevalence of medication-induced osteoporosis: evidence-based review
    Allport, Juliette
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2008, 20 (04) : 435 - 441
  • [4] Medication-induced dysphagia
    Schwemmle, C.
    Jungheim, M.
    Miller, S.
    Kuehn, D.
    Ptok, M.
    [J]. HNO, 2015, 63 (07) : 504 - 510
  • [5] Medication-induced hyperprolactinemia
    Molitch, ME
    [J]. MAYO CLINIC PROCEEDINGS, 2005, 80 (08) : 1050 - 1057
  • [6] MEDICATION-INDUCED RHABDOMYOLYSIS
    CHICHMANIAN, RM
    MIGNOT, G
    SPREUX, A
    [J]. ANNALES DE MEDECINE INTERNE, 1991, 142 (08): : 587 - 591
  • [7] MEDICATION-INDUCED IMPOTENCE
    不详
    [J]. WIENER MEDIZINISCHE WOCHENSCHRIFT, 1987, 137 (14-15) : 361 - 363
  • [8] Medication-induced seizures
    Feeney, DJ
    Klykylo, WM
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1997, 36 (08): : 1018 - 1019
  • [9] MEDICATION-INDUCED HEADACHE
    ALLAIN, HJ
    WEINTRAUB, M
    [J]. INTERNIST, 1981, 22 (06): : 369 - 374
  • [10] MEDICATION-INDUCED ESOPHAGITIS
    AGHA, FP
    WILSON, JAP
    NOSTRAND, TT
    [J]. GASTROINTESTINAL RADIOLOGY, 1986, 11 (01): : 7 - 11